HIV-I Nef inhibitors: a novel class of HIV-specific immune adjuvants in support of a cure
The success of many current vaccines relies on a formulation that incorporates an immune activating adjuvant. This will hold true for the design of a successful therapeutic HIV vaccine targeted at controlling ...